Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anupam Rasayan India Limited Earnings Release 2022

Nov 10, 2021

62593_rns_2021-11-10_3e290385-840d-4685-98c5-3c78f8ea2d0b.pdf

Earnings Release

Open in viewer

Opens in your device viewer

ANUPAM RASAYAN INDIA LTD.

ARILSLDSTX20211110054 Date: November 10, 2021

To, To,
BSE Limited, Sr. General Manager
Phiroze Jeejeebhoy Towers, National Stock Exchange of India Limited
Dalal Street, 'Exchange Plaza', C-1, Block-G,
Mumbai -400001, India Bandra Kurla Complex
SCRIP CODE: 543275 Bandra (East), Mumbai 400051, India
SYMBOL: ANURAS

Dear Sir / Madam,

Sub: Press Release Intimation

Pursuant to Regulation 30 and other applicable regulations, if any of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached Press Release which shall be issued by the Company today i.e. Wednesday November 10, 2021.

This Press Release will be available on the website of the Company www.anupamrasayan.com.

We request you to kindly take note of the same.

Thanking You,

Yours faithfully,

For, Anupam Rasayan India Limited - -

Anand Desai, Managing Director DIN: 00038442

Encl.: As above

Registered Office : 8110, GIDC Industrial Estate, Sachin, SURAT-394 230 Gujarat, India.

Tel. : +91-261-2398991-95 Fax : +91-261-2398996 E-mail : [email protected] Website : www.anupamrasayan.com CIN -L24231GJ2003PLC042988

Anupam Rasayan Reports Q2FY22 Results

Total Revenue of ₹2,552 Mn; growth of 7% YoY Profit After Tax at ₹502 Mn; growth of 37%

Surat, November 10, 2021: Anupam Rasayan India Ltd. (BSE- 543275, NSE- ANURAS, ISIN: INE930P01018), one of India's leading custom synthesis and specialty chemical player, has announced its financial results for the quarter and half year ended September 30, 2021.

Financial Highlights for Second Quarter Ended September 30th, 2021:

  • Total Revenues at ₹2,552 million in Q2FY22 as compared to ₹2,390 million in Q2FY21 growth of 7% Y-o-Y.
  • EBITDA (incl. other revenue) at ₹702 million in Q2FY22 as compared to ₹636 million in Q2FY21 – growth of 10% Y-o-Y.
  • Profit After Tax at ₹361 million in Q2FY22 as compared to ₹263 million in Q2FY21 growth of 37% Y-o-Y.
  • Total debt of ₹ 5,630 Mn repaid as of Q2FY22 from IPO proceeds.

Financial Highlights for First Half Year Ended September 30th, 2021:

  • Total Revenues at ₹4,931 million in H1FY22 as compared to ₹3,736 million in H1FY21 growth of 32% Y-o-Y.
  • EBITDA (incl. other revenue) at ₹1,352 million in H1FY22 as compared to ₹959 million in H1FY21 – growth of 41% Y-o-Y.
  • Profit After Tax at ₹682 million in H1FY22 as compared to ₹265 million in H1FY21 growth of 157% Y-o-Y.

Anand Desai, Managing Director of Anupam Rasayan, commented, "Continuing the momentum further, I am pleased to announce that we have delivered yet another quarter and half year of increased profitability and strengthening balance sheet. Our margins along with metrics like client and geographic concentration have seen improvement even in midst of global raw material prices rising due to our inventory policy and cost-plus model. Our new molecule launches, new export orders, achievement of further debt reduction targets and commissioning of solar plant in Bharuch will give further impetus to our margins going forward. The prudent financial and capital rationing technique that we are sticking to is also helping us deliver sustained growth. I am also pleased to announce that we are at an advance stage to introduce a new molecule under electronic chemical segment, further we are working on various advanced niche molecules which are under pipeline at R&D and pilot level which will be commercialized in coming quarters."

About Anupam Rasayan India Ltd. (ARIL):

Anupam Rasayan India Ltd (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Specialty Pigment and Dyes, and Polymer Additives. The Company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 66 domestic and international customers, including 23 multinational companies. The Company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhagadia, Bharuch with an aggregate installed capacity of about 27,000 MT, as of September 30, 2021.

ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers. The Company is focussed on developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimization.

For further details, please get in touch with:

IR Contact PR Contact Kanav Khanna / Diwakar Pingle Sanchi Yadav [email protected] Phone: + 91 98336 40764 Phone: + 91 9910036240

Email: [email protected] Email: [email protected]